Wall Street Zen Upgrades Bonk (NASDAQ:BNKK) to Hold

Bonk (NASDAQ:BNKK) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings downgraded Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Bonk presently has a consensus rating of “Sell”.

Bonk Stock Performance

NASDAQ:BNKK opened at $1.35 on Friday. The stock’s fifty day moving average is $2.26 and its 200 day moving average is $3.26. Bonk has a fifty-two week low of $1.25 and a fifty-two week high of $46.90. The firm has a market capitalization of $10.80 million, a PE ratio of -0.29 and a beta of 1.85.

Bonk (NASDAQ:BNKK) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The company had revenue of $0.79 million for the quarter.

Insider Transactions at Bonk

In related news, Director Mitchell Austin Rudy bought 31,055 shares of the business’s stock in a transaction on Thursday, April 9th. The shares were bought at an average price of $2.82 per share, for a total transaction of $87,575.10. Following the completion of the purchase, the director directly owned 44,198 shares of the company’s stock, valued at approximately $124,638.36. This trade represents a 236.29% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 51.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On Bonk

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC purchased a new position in Bonk in the fourth quarter valued at about $128,000. Jane Street Group LLC purchased a new position in Bonk in the fourth quarter valued at about $96,000. Steward Partners Investment Advisory LLC purchased a new position in Bonk in the fourth quarter valued at about $37,000. Finally, State Street Corp purchased a new position in Bonk in the fourth quarter valued at about $33,000. Hedge funds and other institutional investors own 12.55% of the company’s stock.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.